The production line independently developed by CATL features a high degree of complexity and intelligence, combined with advanced materials science. This should continue to set high entry barriers, ...

To this session of the Morgan Stanley Global Healthcare Conference. I'm excited to welcome the team from 4D Molecular Therapeutics. Let me just get through a quick disclosure before we get started.

Detailed price information for Molecular Partners Ag ADR (MOLN-Q) from The Globe and Mail including charting and trades.

If you have been weighing what to do with Bristol-Myers Squibb (BMY), recent company updates might make you pause and reconsider your position. At the Morgan Stanley Healthcare Conference, ...

In recent days, BioNTech SE and Bristol Myers Squibb announced positive interim Phase 2 results for pumitamig plus chemotherapy in untreated extensive-stage small cell lung cancer, showing a high ...

Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced that management will participate in ...

Good morning, everyone, and thanks for joining us at the Morgan Stanley Global Healthcare Conference. I'm Mike Ulz, one of the biotech analysts here. It's my pleasure to introduce the team from Dyne ...

A new study indicates that the harsh environment of space travel may accelerate changes in the human body typically associated with aging. The research sent human tissues into low Earth orbit and ...

Medcaptain sells its life-support and testing products in more than 140 countries and regions, with strong positions in ...

Flaxseeds and hemp seeds are nutrient-rich, but one packs more omega-3s to help support heart health. Learn the benefits of ...